Format

Send to

Choose Destination
Diabetes Care. 1992 Feb;15(2):253-5.

Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients.

Author information

1
Department of Psychiatry, University of Pittsburgh School of Medicine, Pennsylvania.

Abstract

OBJECTIVE:

To assess the lifetime prevalence of major depression (MD) and its relation to glycemic control among a group of non-insulin-dependent (type II) diabetic subjects seeking obesity treatment and to determine whether a history of MD affected response to treatment.

RESEARCH DESIGN AND METHODS:

Sixty-six obese subjects with type II diabetes (22 men, 44 women) completed the Inventory to Diagnose Depression-Lifetime Version before a 52-wk behavioral weight-control program. Weight, glycosylated hemoglobin, fasting blood glucose, and mood were assessed at pre- and posttreatment.

RESULTS:

Thirty-two percent of the subjects reported a history of MD. Neither a history of MD nor current depressive symptoms were associated with pretreatment glycemic control. However, a history of MD was related to treatment attrition (52.4 vs. 22.2%, P = 0.03). Subjects with and without a history of MD showed comparable improvements in weight, glycemic control, and mood.

CONCLUSIONS:

A history of MD among type II diabetic patients seeking obesity treatment was not related to pretreatment glycemic control but was associated with higher rates of attrition from treatment. Individuals with a history of MD who completed the program did not differ from those with no history of MD in response to treatment.

PMID:
1547681
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center